7.400
−7,50%
2026-10-19
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -340.4% | -522.0% | 0 / 3 | -64.0% | -55.36 pp | -79.62 pp | -37.0% | 0.31 | — | 23,0 | −64,0% | −15,9 | −340,4% | — | 13.24 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 7.400 (close price on 2026-10-19)EPS (TTM): −3.739,4
Financial charts
1.Revenue & growth
VND bn23,0Q2/26
1.Revenue & growth
VND bn23,0Q2/26
2.Profit & growth
VND bn-15,9Q2/26
3.Profit mix (Penman)
VND bn-31,8Q2/26
4.Margins & cost structure
%-7.6%Q2/26
5.Returns & cash cycle
% · days-19.0%Q2/26
6.Earnings quality & cash
VND bn45,1Q2/26
7.Asset structure
VND bn146Q2/26
8.Funding & debt health
VND bn · times146Q2/26
9.Revenue backlog
VND bn2,71Q2/26
10.Valuation
times · %-2,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-1.856Q2/26
Adjusted EPS growth, latest quarter
-341%
Average adjusted EPS growth, 3 quarters
-523%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.2%
Source: vnstockData through Q2/26